Siqi Feng
- Pharmacology top 10%
- Berberine and alkaloids research 4
- Pharmacology top 10%
- Berberine and alkaloids research 4
-
- Drug Transport and Resistance Mechanisms 5
-
- Kawasaki Disease and Coronary Complications 8
-
- Coronary Artery Anomalies 5
-
- Epigenetics and DNA Methylation 5
- Histone Deacetylase Inhibitors Research 4
- Metabolism, Diabetes, and Cancer 4
- Ginseng Biological Effects and Applications 4
- Partner nations
- ChinaNew ZealandUnited States
In The Last Decade
Siqi Feng
58 papers receiving 844 citations
Peers
Comparison fields: 5 of 119
- Complementary and alternative medicine 84
- Pharmacology 73
- Pharmacology 130
- Neurology 57
- Oncology 162
Countries citing papers authored by Siqi Feng
This map shows the geographic impact of Siqi Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siqi Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siqi Feng more than expected).
Fields of papers citing papers by Siqi Feng
This network shows the impact of papers produced by Siqi Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siqi Feng. The network helps show where Siqi Feng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Siqi Feng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 8 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 3 | |
| 9 | 2023 | 13 | |
| 10 | 2023 | 0 | |
| 11 | 2023 | 1 | |
| 12 | 2023 | 4 | |
| 13 | 2022 | 14 | |
| 14 | 2021 | 12 | |
| 15 | 2018 | 14 | |
| 16 | 2018 | 23 | |
| 17 | 2017 | 36 | |
| 18 | 2017 | 23 | |
| 19 | 2016 | 20 | |
| 20 | 2016 | 59 |
About Siqi Feng
Siqi Feng is a scholar working on Biological Psychiatry, Complementary and alternative medicine and Pharmacology, having authored 63 papers that have together received 850 indexed citations. Recurring topics across this work include Kawasaki Disease and Coronary Complications (8 papers), Drug Transport and Resistance Mechanisms (5 papers), Coronary Artery Anomalies (5 papers), Epigenetics and DNA Methylation (5 papers), Histone Deacetylase Inhibitors Research (4 papers), Metabolism, Diabetes, and Cancer (4 papers), Berberine and alkaloids research (4 papers) and Ginseng Biological Effects and Applications (4 papers). The work is most often cited by research in Complementary and alternative medicine (84 citations), Pharmacology (73 citations) and Pharmacology (130 citations). Siqi Feng has collaborated with scholars based in China, New Zealand and United States. Frequent co-authors include Guangji Wang, Jiye Aa, Runbin Sun, Fang Zhou, Jingqiu Huang, Na Yang, Qijian Yi, Chun Ge, Jianliang Geng and Fei Fei. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.